Pharma News

PARIS (Reuters) - French drugmaker Sanofi (SASY.

Novartis has terminated its sponsored hydroxychloroquine clinical trial for COVID-19 due to acute enrolment challenges that have made trial completion “infeasible”.

(Reuters) - Gilead Sciences Inc expects supply of its potential COVID-19 drug remdesivir to exceed two million courses by year-end, the company said on Monday, more than double its previous ta...

BEIJING (Reuters) - China’s capital will see a “cliff-like” drop in new cases in a recent outbreak of the novel coronavirus by the end of this week with efforts to cut chains of transmis...

Novo Nordisk has unveiled headline results from two clinical trials with a novel once-weekly subcutaneous amylin analogue (AM833) - a Phase II monotherapy trial and a Phase I combination trial...

GAITHERSBURG, Md.

A study conducted by researchers at Julius-Maximilians-Universität Würzburg has shown that the antidepressant agent fluoxetine may be an effective drug for the early treatment of severe acute respir...

Under accelerated review status, the FDA approves Epizyme's (EPZM +4.

MSD and Pfizer have unveiled data from the Phase III VERTIS CV cardiovascular (CV) outcomes trial which add further evidence on the safety of their diabetes drug Steglatro (ertugliflozin&#...

UCLA engineers have designed a thin adhesive film that could upgrade a consumer smartwatch into a powerful health-monitoring system.

Today, the U.

Eyeing blockbuster sales for its cardiovascular drug Vascepa, Amarin took a nightmarish hit in March when a federal judge struck down key patents.